Cargando…
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
The outbreak of coronavirus disease 2019 (COVID-19) is a global pandemic. Many clinical trials have been performed to investigate potential treatments or vaccines for this disease to reduce the high morbidity and mortality. The drugs of higher interest include umifenovir, bromhexine, remdesivir, lop...
Autores principales: | Law, Man Fai, Ho, Rita, Law, Kimmy Wan Tung, Cheung, Carmen Ka Man |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727202/ https://www.ncbi.nlm.nih.gov/pubmed/35069994 http://dx.doi.org/10.4254/wjh.v13.i12.1850 |
Ejemplares similares
-
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases
por: Cheung, Carmen Ka Man, et al.
Publicado: (2023) -
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
por: Mak, Joyce Wing Yan, et al.
Publicado: (2023) -
Transfusion-transmitted hepatitis E: What we know so far?
por: Cheung, Carmen Ka Man, et al.
Publicado: (2022) -
Massive pulmonary embolism in a patient with polysplenia syndrome and interrupted inferior vena cava with azygous continuation
por: Cheung, Carmen K. M., et al.
Publicado: (2017) -
Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
por: Lam, Yuk Fai, et al.
Publicado: (2018)